Dysfunctional Voiding
15
1
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
1 terminated out of 15 trials
88.9%
+2.3% vs benchmark
13%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (15)
New Generation Rehabilitation Approach in Children With Dysfunctional Voiding
Standard Urotherapy With or Without Biofeedback Based Pelvic Floor Muscle Training for Dysfunctional Voiding in Children
Standard Urotherapy for Dysfunctional Voiding in Children
Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Biofeedback for Dysfunctional Voiding and Giggle Incontinence
Use of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction
At-Home Diaphragmatic Interventions for Voiding Abnormalities (DIVA)
OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.
Case Control Study to Investigate the Use of Urethral Pressure Profile Measurement in Children
Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding
Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
Diaphragmatic Breathing Exercises and Pelvic Floor Retraining in Children With Dysfunctional Voiding
The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)
Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding
Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale